You searched for Humanized antibody - Page 28 of 44

News and Trends 1 Jun 2017

Next-Gen Drug Conjugates Bank €46M in Series B with American Investors

…the drug behaves like an antibody-drug conjugate with an engineered bicyclic peptide instead of an antibody. BT1718’s small size of 1.5 to 2 kDa allows it to enter a solid…

June 1, 2017 - 3 minutesmins - By Evelyn Warner

antibody drug conjugate adc small cancer treatment

News and Trends 30 Nov 2022

SOTIO exercises option on ADC program

SOTIO Biotech, a clinical stage immuno-oncology company owned by PPF Group, has exercised its first of five exclusive, target-specific options with LegoChem Biosciences (LCB) for antibody-drug conjugate (ADC) SOT106, which…

November 30, 2022 - 2 minutesmins - By Jim Cornall

ulf grawunder nbe therapeutics interview

Interview 4 Oct 2017

4th-Generation ADCs: Meet the Swiss Startup Perfecting the Technology

ADC development has progressed to the fourth generation. Serial entrepreneur Ulf Grawunder told me what NBE is doing differently from its predecessors. Ever since the first antibody-drug conjugate (ADC) was…

October 4, 2017 - 5 minutesmins - By Evelyn Warner

Best in Biotech 19 Aug 2025

10 biotech companies you should know about in Spain

…safety and efficacy of leriglitazone for the treatment of Rett syndrome. Ona Therapeutics Technology: Antibody-drug conjugates Disease area: Oncology Recent news: Partnered with REVEAL GENOMICS to accelerate the clinical development…

August 19, 2025 - 16 minutesmins - By Willow Shah-Neville

News and Trends 29 Jun 2018

Update: Yet Another ADC Company Makes Bank, This Time in Series B

…Basel-based biotech making its debut as a player in antibody drug conjugates (ADCs). It just raised 20M CHF in Series B, with PPF leading the way. With the funds, NBE…

June 29, 2018 - 3 minutesmins - By Editorial Team

News and Trends 14 Oct 2022

Mablink Bioscience receives €31M series A funding for ADC pipeline

French biotech company Mablink Bioscience has raised €31 million ($30.3 million) in series A funding to advance its lead candidate to the clinic and to build a pipeline of antibody…

October 14, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 25 Sep 2019

German Biotech Will Develop Carbohydrate-Targeting Cancer Treatments

The German startup Tacalyx has raised €7M in a seed round to fund the preclinical development of first-in-class carbohydrate-targeting antibody drugs for the treatment of cancer. The round was co-led…

September 25, 2019 - 2 minutesmins - By Jonathan Smith

Best in Biotech 28 Jul 2023

Six companies driving Chennai’s biotech scene

…modified peptides of large quantities. It also conducts epigenomic profiling which entails chromatin, RNA sequencing and DNA methylation analysis. The Chennai-based biotech company’s antibody development includes production of antibody fragments…

July 28, 2023 - 7 minutesmins - By Roohi Mariam Peter

News and Trends 17 Jul 2020

Two UK Startups Raise Seed Funding to Revolutionize Cancer Treatment

…is developing engineered antibodies called antibody-drug conjugates, which are designed to recognize cancer cells and release their chemotherapy drug payload in a targeted manner. This idea has been explored by…

July 17, 2020 - 3 minutesmins - By Kostas Vavitsas

More News! 12 Nov 2018

This UK Biotech Wants to Make Antibodies Easy to Swallow

Say goodbye to painful antibody injections. The UK biotech Intract Pharma has received a €1.6M grant to advance oral immunotherapy based on approved antibodies, causing less discomfort for patients. The…

November 12, 2018 - 2 minutesmins - By Jonathan Smith

In Depth 4 Dec 2024

Idiopathic pulmonary fibrosis: Refoxy, Boehringer, Insilico, and more on the hunt for curative treatments

…several failed clinical attempts to beat Ofev and Esbriet. These include California-based FibroGen’s anti-CTGF antibody pamrevlumab, Belgian biotech Galapagos and Gilead’s autotaxin inhibitor ziritaxestat, and Massachusetts-based Galecto’s galectin-3 inhibitor GB0139,…

December 4, 2024 - 8 minutesmins - By Roohi Mariam Peter

In Depth 9 May 2024

BTK inhibitors: can these drugs tackle cancer and autoimmunity?

…soon, rilzabrutinib could give competition to Swiss multinationals Novartis and Roche’s monoclonal antibody Xolair, which is also given to patients with CSU. Moreover, the readout of the phase 2 asthma…

May 9, 2024 - 7 minutesmins - By Roohi Mariam Peter

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Humanized antibody

Next-Gen Drug Conjugates Bank €46M in Series B with American Investors

SOTIO exercises option on ADC program

4th-Generation ADCs: Meet the Swiss Startup Perfecting the Technology

10 biotech companies you should know about in Spain

Update: Yet Another ADC Company Makes Bank, This Time in Series B

Mablink Bioscience receives €31M series A funding for ADC pipeline

German Biotech Will Develop Carbohydrate-Targeting Cancer Treatments

Six companies driving Chennai’s biotech scene

Two UK Startups Raise Seed Funding to Revolutionize Cancer Treatment

This UK Biotech Wants to Make Antibodies Easy to Swallow

Idiopathic pulmonary fibrosis: Refoxy, Boehringer, Insilico, and more on the hunt for curative treatments

BTK inhibitors: can these drugs tackle cancer and autoimmunity?

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!